Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

CME, new financial framework and trading update

14th Oct 2026 07:00

RNS Number : 8203Y
Porvair PLC
14 October 2026
 

             

14 October 2026

 

 

Porvair plc

("Porvair" or the "Group")

Capital Markets Event, new financial framework and ten-month trading update

Continued strong trading, with full-year trading anticipated to be slightly ahead of market expectations

Porvair plc, the specialist filtration, laboratory and environmental technology group, will today host a Capital Markets Event (“CME”) for analysts and investors at 13:30 BST in London, with registration from 13:00 BST. Ahead of the CME, the Group announces a trading update for the ten months ended 30 September 2026.

Current trading and outlook

Further to the nine-month trading update announced on 22 September 2026, the Group has continued to trade well with a strong start to the final quarter. All three divisions are showing organic revenue growth, with the Group’s adjusted operating profit margin being slightly ahead of the prior ten-month period. The Group remains in a modest net cash position, excluding lease liabilities, despite having completed the acquisition of Drache Umwelttechnik GmbH, Carekem Limited and GV Filtri Industriali S.r.l. during the period. The Board expects trading to be slightly ahead of full-year market expectations, supported by a diversified customer base, strong recurring revenue streams and disciplined operational management.

No additional information on current trading will be disclosed at the CME.

Capital Markets Event, including new medium-term financial framework

The event will showcase the next phase of the Group's development following more than 20 years of consistent compounding. The presentation will highlight Porvair's portfolio of specialist technology businesses, which benefit from attractive end markets, mission-critical products, technical differentiation, high recurring revenues and disciplined capital allocation.

Attendees will gain insight into Porvair’s future ambition, strategic priorities and the structural growth drivers supporting demand across its Aerospace & Industrial, Laboratory, and Metal Melt Quality divisions. Demonstrations of the Group’s products and technologies from across the portfolio will provide attendees with first-hand experience of the Group’s specialist approach and expertise.

The Group will also provide further detail on the new medium-term financial framework set out below:

Total revenue growth of 10%+Mid-single-digit organic constant currency revenue growthAdjusted operating profit margins to reach 16 – 18%1Adjusted EPS growth of 10 – 20%Operating cash flow conversion of 85%+Return on Invested Capital of 18%+

Presentation materials will be made available at the start of the event at www.porvair.com. A recording of the event will be made available as soon as is practicable.

For further information, please contact:

Porvair plc

+44 (0)1553 765 500

Hooman Caman Javvi, Chief Executive Officer

 

James Mills, Chief Financial Officer

 

 

Alma Strategic Communications

+44 (0)20 3405 0205

Andrew Jaques / Josh Royston / Hannah Campbell / Rose Docherty

 

 

 

Notes to editors

Porvair is a group of specialist filtration, laboratory and environmental technology companies. Our businesses design and manufacture bespoke consumable filtration products that are used in a range of niche markets. It operates in three divisions: Aerospace & Industrial; Laboratory; and Metal Melt Quality.


1 FY31 range

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTGPGRGUUPQGMW

Related Shares:

Porvair
FTSE 100 Latest
Value10,840.35
Change115.49